Akyso

Akyso email format

Verified email-pattern data for Akyso is currently limited. You can still use the company insights and contact sections below.
We are a research and development firm focusing on bringing forward a medication for opioid use disorder. Our firm is developing a sustained-release, subcutaneous naltrexone implant that will deliver the drug for at least six months. Once approved, this will be the first new treatment for opioid use disorder to come on the market since 2006. Pre-clinical studies have shown that our product is safe and effective. Phase 1 human clinical studies are projected to begin in Q2 2023.
Looking for a particular Akyso employee's phone or email?

Akyso Questions

Explore related pages

Related company profiles:

Top Akyso Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant